Boehringer Ingelheim receives EMA marketing authorization for NexGard COMBO, the first isoxazoline-based full endectocide for cats
Boehringer Ingelheim receives EMA marketing authorization for NexGard COMBO, the first isoxazoline-based full endectocide for cats This innovative broad spectrum topical parasiticide is easy and convenient for cat owners. It kills a wider range of parasites than any other product on the market, covering core external parasites like fleas and ticks as well as internal parasites, including tapeworms. Boehringer Ingelheim, a global leader in animal health, is proud to announce that it has received marketing authorization from the EMA (European Medicine Agency) and European Commission for its Nex...